{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:46:02Z","timestamp":1758980762778},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T00:00:00Z","timestamp":1390521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00105-013-2747-2","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T11:30:41Z","timestamp":1390390241000},"page":"548-552","source":"Crossref","is-referenced-by-count":6,"title":["Arzneimittelinduzierter subakuter kutaner Lupus erythematodes"],"prefix":"10.1007","volume":"65","author":[{"given":"G.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,24]]},"reference":[{"key":"2747_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","volume":"44","author":"Bonsmann","year":"2001","unstructured":"Bonsmann G, Schiller M, Luger TA, St\u00e4nder S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44:925\u2013931","journal-title":"J Am Acad Dermatol"},{"key":"2747_CR2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2133.1998.2576q.x","volume":"139","author":"Brooke","year":"1998","unstructured":"Brooke R, Coulson IH, Al-Dawoud A (1998) Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 139:1132\u20131133","journal-title":"Br J Dermatol"},{"key":"2747_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archderm.139.1.89","volume":"139","author":"Callen","year":"2003","unstructured":"Callen JP (2003) How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus? Arch Dermatol 139:89\u201390","journal-title":"Arch Dermatol"},{"key":"2747_CR4","first-page":"889","volume":"10","author":"Dalle","year":"2012","unstructured":"Dalle Vedove C, Simon JC, Girolomoni G (2012) Drug-induced lupus erythematosus with emphasis on skins manifestations and the role of anti-TNF\u03b1 agents. J Dtsch Dermatol Ges 10:889\u2013897","journal-title":"J Dtsch Dermatol Ges"},{"key":"2747_CR5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0190-9622(84)70198-8","volume":"11","author":"Deng","year":"1984","unstructured":"Deng JS, Sontheimer RD, Gilliam JN (1984) Relationships between antinuclear and anti-Ro\/SS-A antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol 11:494\u2013499","journal-title":"J Am Acad Dermatol"},{"key":"2747_CR6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archdermatol.2010.258","volume":"146","author":"Funke","year":"2010","unstructured":"Funke AA, Kulp-Shorten CL, Callen JP (2010) Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy. Arch Dermatol 146:1113\u20131116","journal-title":"Arch Dermatol"},{"key":"2747_CR7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1365-2249.1999.01026.x","volume":"118","author":"Furukawa","year":"1999","unstructured":"Furukawa F, Itoh T, Wakita H et al (1999) Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol 118:164\u2013170","journal-title":"Clin Exp Immunol"},{"key":"2747_CR8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","volume":"164","author":"Gr\u00f6nhagen","year":"2011","unstructured":"Gr\u00f6nhagen CM, Fored CM, Granath F, Nyberg F (2011) Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 164:1335\u20131341","journal-title":"Br J Dermatol"},{"key":"2747_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00105-006-1094-y","volume":"57","author":"Kuhn","year":"2006","unstructured":"Kuhn A, Gensch K, St\u00e4nder S, Bonsmann G (2006) Kutaner Lupus erythematodes. Teil 1: Klinik und Klassifikation. Hautarzt 57:251\u2013268","journal-title":"Hautarzt"},{"key":"2747_CR10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1610-0387.2008.06806_supp.x","volume":"6","author":"Lorentz","year":"2008","unstructured":"Lorentz K, Booken N, Goerdt S, Goebeler M (2008) Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. J Dtsch Dermatol Ges 6:823\u2013827","journal-title":"J Dtsch Dermatol Ges"},{"key":"2747_CR11","first-page":"465","volume":"164","author":"Lowe","year":"2011","unstructured":"Lowe G, Henderson CL, Grau RH et al (2011) A systemic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol 164:465\u2013472","journal-title":"Br J Dermatol"},{"key":"2747_CR12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","volume":"18","author":"Marzano","year":"2009","unstructured":"Marzano AV, Vezzoli P, Crosti C (2009) Drug-induced lupus: an update on its dermatologic aspects. Lupus 18:935\u2013940","journal-title":"Lupus"},{"key":"2747_CR13","first-page":"653","volume":"55","author":"Mattes","year":"2004","unstructured":"Mattes T, Hagedorn M (2004) Terbinafin-induzierter subakuter-kutaner Lupus erythematodes. Farbbildkasuistik und Literatur\u00fcbersicht. Hautarzt 55:653\u2013657","journal-title":"Hautarzt"},{"key":"2747_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000018307","volume":"200","author":"Parodi","year":"2000","unstructured":"Parodi A, Caproni M, Cardinali C et al (2000) Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology. Dermatology 200:6\u201310","journal-title":"Dermatology"},{"key":"2747_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-008-0890-x","volume":"301","author":"Sontheimer","year":"2009","unstructured":"Sontheimer RD, Henderson CL, Grau RH (2009) Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 301:65\u201370","journal-title":"Arch Dermatol Res"},{"key":"2747_CR16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0733-8635(18)30462-5","volume":"8","author":"Sontheimer","year":"1990","unstructured":"Sontheimer RD, McCauliffe DP (1990) Pathogenesis of anti-Ro\/SSA autoantibody-associated cutaneous lupus erythematosus. Dermatol Clin 8:751\u2013758","journal-title":"Dermatol Clin"},{"key":"2747_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archderm.139.1.45","volume":"139","author":"Srivastava","year":"2003","unstructured":"Srivastava M, Rencic A, Diglio G et al (2003) Drug-induced, Ro\/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 139:45\u201349","journal-title":"Arch Dermatol"},{"key":"2747_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/0961203306070000","volume":"15","author":"Vasoo","year":"2006","unstructured":"Vasoo S (2006) Drug-induced lupus: an update. Lupus 15:757\u2013761","journal-title":"Lupus"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2747-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2747-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2747-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T12:12:38Z","timestamp":1597407158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2747-2"}},"subtitle":["Wiederholtes Auftreten nach Einnahme von Terbinafin"],"short-title":[],"issued":{"date-parts":[[2014,1,24]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2747-2","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,24]]}}}